Am. J. Respir. Cell Mol. Biol., Vol 14, No. 3, 03 1996, 279-287.
Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma
B Galve-de Rochemonteix, LP Nicod and JM Dayer
Division of Immunology and Allergy, Hans Wilsdorf Laboratory, Geneva, Switzerland.
Tumor necrosis factor alpha(TNF alpha), a proinflammatory cytokine secreted
predominantly by monocytemacrophages, interacts with two cell- surface
receptors: TNF-R55 and TNF-R75. Few studies have been devoted to their
modulation on human alveolar macrophages (AM). Both source and target of
TNF(alpha), AM also release its inhibitors, the soluble receptors,
following the cleavage of the extracellular domain of TNF- R55 and TNF-R75.
Because in vivo AM are subject to activation by exogenous or endogenous
stimuli, we analyzed the release of both receptors into the cell culture
supernatant in response to lipopolysaccharide (LPS), phorbol myristate
acetate (PMA), and cytokines such as interleukin 2(IL-2), IL-4, IL-6,
granulocyte- macrophage colony-stimulating factor (GM-CSF), and interferon
gamma (IFN-gamma). Results were compared with those obtained on peripheral
blood monocytes (Mo), and the role of receptor recycling was investigated
using inhibitors such as monensin and chloroquine. In our culture
conditions, basal release by unstimulated AM amounted to 0.3 +/- 0.1 and
0.5 +/- 0.1 ng/ml for TNF-sR55 and TNF-sR75, respectively. In the same
conditions, Mo released 1.2 +/- 1.2 ng/ml of TNF-sR55 and 5.1 +/- 0.1 ng/ml
of TNF-sR75. PMA slightly increased mRNA expression and release of
TNF-sR55, but those of TNF-sR75 were enhanced approximately 4-fold. After
24 h of culture, the release of TNF-sR75 was 2.5-fold higher on Mo than on
AM. Of the cytokines tested on AM, IFN-gamma increased the release of
TNF-sR75 3-fold, but that of TNF-sR55 only between 1.5- and 2-fold. GM-CSF
enhanced them to a lower extent (approximately 1.5-fold). Shedding occurred
despite the presence of chloroquine, monensin and colchicine, suggesting
that cleavage takes place on the cell surface rather than after
internalization. Addition of colchicine increased the release of TNF-sR75
induced by LPS and IFN- gamma, but not by PMA. In conclusion, Mo and AM
differ in their ability to release TNF(alpha) and TNF-sR. On AM the release
of each receptor appears to be regulated separately. Finally, IFN-gamma was
among the most efficacious cytokines to induce the release of both
receptors, with TNF-sR75 being more liable to shedding. Thus, the two TNF-R
seem to be ruled by separate mechanisms and to differ in terms of release
sensitivity.
This article has been cited by other articles:

|
 |

|
 |
 
T. Pedron, R. Girard, and R. Chaby
TLR4-dependent Lipopolysaccharide-induced Shedding of Tumor Necrosis Factor Receptors in Mouse Bone Marrow Granulocytes
J. Biol. Chem.,
May 30, 2003;
278(23):
20555 - 20564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gumenscheimer, I. Mitov, C. Galanos, and M. A. Freudenberg
Beneficial or Deleterious Effects of a Preexisting Hypersensitivity to Bacterial Components on the Course and Outcome of Infection
Infect. Immun.,
October 1, 2002;
70(10):
5596 - 5603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.P. Coyne, T. Howell, H. Smodlaka, C. Willetto, B. W. Fenwick, and E. Chenney
Alterations in membrane-associated CD14 expression and the simultaneous liberation of soluble CD14 fragment in adherent macrophages mediated by a leukocyte carboxyl/aspartate protease
Innate Immunity,
August 1, 2002;
8(4):
273 - 283.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M J Plummeridge, L Armstrong, M A Birchall, and A B Millar
Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects
Thorax,
October 1, 2000;
55(10):
842 - 847.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K F Chung and P J Barnes
Cytokines in asthma
Thorax,
September 1, 1999;
54(9):
825 - 857.
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Armstrong, N. M Foley, and A. B Millar
Inter-relationship between tumour necrosis factor-alpha (TNF-alpha ) and TNF soluble receptors in pulmonary sarcoidosis
Thorax,
June 1, 1999;
54(6):
524 - 530.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev.,
December 1, 1998;
50(4):
515 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Balcewicz-Sablinska, J. Keane, H. Kornfeld, and H. G. Remold
Pathogenic Mycobacterium tuberculosis Evades Apoptosis of Host Macrophages by Release of TNF-R2, Resulting in Inactivation of TNF-{alpha}
J. Immunol.,
September 1, 1998;
161(5):
2636 - 2641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tinkle and L. Newman
Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease
Am. J. Respir. Crit. Care Med.,
December 1, 1997;
156(6):
1884 - 1891.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. M. VISCARDI, J. D. HASDAY, K. F. GUMPPER, V. TACIAK, A. B. CAMPBELL, and T. W. PALMER
Cromolyn Sodium Prophylaxis Inhibits Pulmonary Proinflammatory Cytokines in Infants at High Risk for Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med.,
November 1, 1997;
156(5):
1523 - 1529.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. P. Nicod and P. Isler
Alveolar Macrophages in Sarcoidosis Coexpress High Levels of CD86 (B7.2), CD40, and CD30L
Am. J. Respir. Cell Mol. Biol.,
July 1, 1997;
17(1):
91 - 96.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1996 American Thoracic Society.
|
|
|